PDE-5 inhibitors

Alona Crowder, PharmD, Ari S. Eckman, M.D.
PDE-5 inhibitors is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of erectile dysfunction (ED)
  • Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening (Revatio and Adcirca)
  • Treatment of benign prostatic hyperplasia (Cialis)

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of erectile dysfunction (ED)
  • Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening (Revatio and Adcirca)
  • Treatment of benign prostatic hyperplasia (Cialis)

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 7, 2018